NF-kB signaling in the control of Hematopoiesis

NF-kB 信号传导在造血控制中的作用

基本信息

项目摘要

Project Summary: NF-κB signaling pathway is one of the most extensively studied and understood pathways, however, the physiological impact of augmented NF-κB signaling in hematopoiesis has not been understood. Despite many recent studies documenting constitutive activation of NF-κB in patients with hematological disorders, including AML and MDS, it is remains unclear if constitutive NF-κB signaling is sufficient and/or necessary for the onset of the disease. Recently, we have shown that lack of A20 (a negative regulator of NF-κB) in hematopoietic stem cells (HSCs) causes loss of quiescence and severe hematologic abnormalities, due to constitutive NF-κB activation. In an attempt to decipher the role of NF-κB in HSCs, directly , we engineered mice to constitutively activate NF-κB in HSCs. Our preliminary data indicate that HSC quiescence and pool were completely lost, and that increased NF-κB signal alone was sufficient to disturb the transcriptional regulatory circuits of HSCs. In the proposed research, we would like to decode the potential molecular mechanisms through which increased NF-κB signals affect HSC biology. Our hypothesis is that deregulated canonical NF-κB signals impair hematopoietic stem cell (HSC) quiescence and functions by altering signal transduction pathways, `transcription factor networks' and expression of pro-inflammatory cytokines. To test this hypothesis, we will use a combination of genetic, molecular cell biology and biochemical approaches. In specific aim 1, we will decipher the intrinsic mechanisms through which NF-κB affects HSC functions. In specific aim 2, we will unravel the extrinsic role of NF-κB in the control of HSCs. In specific aim 3, we would generate a novel humanized mouse model and decode the involvement of NF-κB signals in human HSC biology. We believe that the proposed research will provide key insights into the pathologic processes involving deregulated NF-κB signals, and will aid the development of newer and more successful therapies for human hematologic diseases that arise due to constitutive NF-κB activation.
项目摘要: NF-κB信号通路是研究和理解最广泛的一种 然而,途径,增强NF-κB信号在中的生理影响 尽管最近有许多研究记录了造血作用。 血液疾病患者的NF-κB的征服激活,倾斜AML 和MDS,它仍然是毫无意义的NF-κB信号,是选举权和或或或或或或或 对于疾病的发作所必需的。 NF-κB的负调节剂)在造血干细胞(HSC)中导致丧失 由于组成型NF-κB激活,静止和严重的血液学异常。 为了使NF-κB在HSC中的作用中解密,我们将小鼠设计为 征兵激活HSC中的NF-κB。 静止和池完全丢失,仅增加NF-κB信号是 足以干扰提议中HSC的转录调节回路 研究,我们想解码潜在的分子机制 NF-κB信号的增加会影响HSC生物学。 我们的假设是,牙本质的规范NF-κB信号受损造血症。 干细胞(HSC)静止和功能通过改变信号转导 途径,“转录因子网络”和促炎的表达 细胞因子。为了检验这一假设,我们将使用遗传,分子细胞的组合 生物学和生化方法。 机理Thich NF-κB会影响特定目标的HSC功能。 揭开NF-κB在特定目标中的控制中的外在作用。 生成一种新型的人性化小鼠模型并解码NF-κB的参与 人类HSC生物学中的信号。 我们认为,支撑研究将为您提供关键的见解 涉及失调的NF-κB信号的病理过程,将有助于发展 由于应得的新的,更成功的Heman血液学疾病疗法 征服NF-κB激活。

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Constitutive Activation of NF-κB Pathway in Hematopoietic Stem Cells Causes Loss of Quiescence and Deregulated Transcription Factor Networks.
Class I PI3K regulatory subunits control differentiation of dendritic cell subsets and regulate Flt3L mediated signal transduction.
  • DOI:
    10.1038/s41598-022-16548-x
  • 发表时间:
    2022-07-19
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Thummar, Keyur;Rathinam, Chozha Vendan
  • 通讯作者:
    Rathinam, Chozha Vendan
Traumatic brain injury alters dendritic cell differentiation and distribution in lymphoid and non-lymphoid organs.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Chozha Vendan Rathinam其他文献

Chozha Vendan Rathinam的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Chozha Vendan Rathinam', 18)}}的其他基金

NF-kB signaling in the control of Hematopoiesis
NF-kB 信号传导在造血控制中的作用
  • 批准号:
    9238854
  • 财政年份:
    2017
  • 资助金额:
    $ 38.63万
  • 项目类别:
GENETIC & MOLECULAR CONTROL OF E3 UBIQUITIN LIGASES IN STEM DIFFERENTIATION
基因
  • 批准号:
    8360045
  • 财政年份:
    2011
  • 资助金额:
    $ 38.63万
  • 项目类别:

相似海外基金

Genetically faithful modeling of NUP98 rearrangement and co-alterations in acute myeloid leukemia
急性髓性白血病中 NUP98 重排和共同改变的遗传忠实模型
  • 批准号:
    10599975
  • 财政年份:
    2021
  • 资助金额:
    $ 38.63万
  • 项目类别:
Genetically faithful modeling of NUP98 rearrangement and co-alterations in acute myeloid leukemia
急性髓性白血病中 NUP98 重排和共同改变的遗传忠实模型
  • 批准号:
    10443579
  • 财政年份:
    2021
  • 资助金额:
    $ 38.63万
  • 项目类别:
Uncovering novel roles for splicing factor SF3B1 in transcription dynamics, R-loop metabolism, and chromatin structure
揭示剪接因子 SF3B1 在转录动力学、R 环代谢和染色质结构中的新作用
  • 批准号:
    9910740
  • 财政年份:
    2020
  • 资助金额:
    $ 38.63万
  • 项目类别:
Experimental and preclinical modeling of NUP98-rearranged acute leukemia
NUP98重排急性白血病的实验和临床前模型
  • 批准号:
    10230529
  • 财政年份:
    2019
  • 资助金额:
    $ 38.63万
  • 项目类别:
Project 4
项目4
  • 批准号:
    10230530
  • 财政年份:
    2019
  • 资助金额:
    $ 38.63万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了